Columns

Why pills became the most popular first DMTs for MS

Note: This column describes the author’s own experiences with several disease-modifying therapies for multiple sclerosis. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Times, they’ve been a-changing for disease-modifying therapies (DMTs). When I was diagnosed with multiple…

MS news notes: Stem cell therapy, genetic variant, diet

Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Another study shows positive results with stem cell therapy Yet another study has concluded that autologous hematopoietic…

MS news notes: Clemastine, MS retrospective, PIPE-791

Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Myelin repair and clemastine The Multiple Sclerosis News Today story “MRI method detects myelin repair with…

I can’t make my own bed or even lie in it!

For most of the past six years, I’ve been suffering from that weekly journo disease known as “columnitis.” One column is finished, hurrah! Bathe in the relief of getting that one in the net. (It’s a football reference, American “Ted Lasso” finale fans.) We’ve also just had the…

Air4All hopes to make flying with a wheelchair easier

I’ve done quite a bit of flying, for business and pleasure, over the 42 years I’ve lived with multiple sclerosis (MS). It’s not easy traveling by air with my scooter, and I can’t imagine trying to fly with a 450-pound power wheelchair. Actually, I don’t have to imagine.

MS news notes: Foralumab, Ocrevus, Kesimpta, exercise

Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Foralumab shows early positive results for SPMS I’ll say up front that this is a very small study.

MS news notes: Frexalimab, vidofludimus calcium, Briumvi

Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Is CD40L a better way to control MS inflammation? CD40L is a protein that’s involved with activation of…

Up at 9, in bed by 8, yet still no time?

My sleep schedule, according to mathematics, leaves me 11 hours — so what’s my problem? My current ultra-efficient carers arrive at 9:30 a.m. and usually get me into the wet room 15 minutes later. Maybe 20 if my bottom has been misbehaving. It’s been something of a miscreant ever since…

Let’s talk facts about MS and COVID-19 vaccines

Since the early days of the COVID-19 vaccination program, disinformation claiming that the vaccines can induce multiple sclerosis (MS) has swirled around social media. Recently, there’s been a resurgence of this type of post, sparked by a report published on the World Health Organization (WHO) website titled “…